Tennessee Theatre Killer Vincente Montano, 29 Diagnosed with Paranoid Schizophrenia

This recent attempted murder of his family is one of a long line of Theater, Malls and Campus killing areas in 2015. A person who is diagnosed paranoid schizophrenic will be given psychotropic drugs. The kind of drugs that are prescribed to treat schizophrenia is a long long list. Some of these are Seroquel, Abilify, Zyprexa, Risperdal, Latuda, Invega and many many more. Too many more.

Many have seen these drugs commercials where people are smiling, laughing, enjoying friends in the outdoors. As if these drugs take a person who is paranoid schizophrenic into happiness. Where is the truth in advertising?

Well Vincente Montano was homeless, and wearing dingy cloths according to witnesses. He was not the happy TV commercial or magazine image that is portrayed by these drug pushers. He was reported missing by his family just two days before. Additionally, he had been committed four times to mental health “professionals”

So do you really think psychiatry works? Do you really think psychiatry is the answer? If this was an act of terror by outside forces then a full analysis and criminal investigations would be taken to address it. But if it is a mental health issue then the media and the government will not confront the drug makers or psychiatry "doctors". No, there is too much money in psych drugs to do that.

If you thinking of putting your child or loved one on psych drugs, then think of all the theaters, malls and campuses where these killings and attempted murders take place.
There are other real solutions to psych drugs. Read more find out more. There are natural remedies, non-drug remedies. Dianetics and Scientology are real methods that address issues of depression and problems in people’s lives. These are practical non drug methods to improve a person’s situation in life.

Has America Become a Nation of Psychotics on Psychotics?

(photovecteezy)

An article reprint by James Ridgeway who writes for The Guardian newspaper, and is the senior Washington correspondent for Mother Jones magazine.

You would certainly think so, based on the explosion in the use of antipsychotic medications. In 2008, with over $14 billion in sales, antipsychotics became the single top-selling therapeutic class of prescription drugs in the United States, surpassing drugs used to treat high cholesterol and acid reflux.
Once upon a time, antipsychotics were reserved for a relatively small number of patients with hard-core psychiatric diagnoses - primarily schizophrenia and bipolar disorder - to treat such symptoms as delusions, hallucinations, or formal thought disorder. Today, it seems, everyone is taking antipsychotics. Parents are told that their unruly kids are in fact bipolar, and in need of anti-psychotics, while old people with dementia are dosed, in large numbers, with drugs once reserved largely for schizophrenics. Americans with symptoms ranging from chronic depression to anxiety to insomnia are now being prescribed anti-psychotics at rates that seem to indicate a national mass psychosis.
It is anything but a coincidence that the explosion in antipsychotic use coincides with the pharmaceutical industry's development of a new class of medications known as "atypical antipsychotics." Beginning with Zyprexa, Risperdal, and Seroquel in the 1990s, followed by Abilify in the early 2000s, these drugs were touted as being more effective than older antipsychotics like Haldol and Thorazine. More importantly, they lacked the most noxious side effects of the older drugs - in particular, the tremors and other motor control problems.
The atypical anti-psychotics were the bright new stars in the pharmaceutical industry's roster of psychotropic drugs - costly, patented medications that made people feel and behave better without any shaking or drooling. Sales grew steadily, until by 2009 Seroquel and Abilify numbered fifth and sixth in annual drug sales, and prescriptions written for the top three atypical antipsychotics totaled more than 20 million. Suddenly, antipsychotics weren't just for psychotics any more.
Not just for psychotics anymore
By now, just about everyone knows how the drug industry works to influence the minds of American doctors, plying them with gifts, junkets, ego-tripping awards, and research funding in exchange for endorsing or prescribing the latest and most lucrative drugs. "Psychiatrists are particularly targeted by Big Pharma because psychiatric diagnoses are very subjective," says Dr. Adriane Fugh-Berman, whose Pharmed Out project tracks the industry's influence on American medicine, and who last month hosted a conference on the subject at Georgetown. A shrink can't give you a blood test or an MRI to figure out precisely what's wrong with you. So it's often a case of diagnosis by prescription. (If you feel better after you take an anti-depressant, it's assumed that you were depressed.) As the researchers in one study of the drug industry's influence put it, "the lack of biological tests for mental disorders renders psychiatry especially vulnerable to industry influence." For this reason, they argue, it's particularly important that the guidelines for diagnosing and treating mental illness be compiled "on the basis of an objective review of the scientific evidence" - and not on whether the doctors writing them got a big grant from Merck or own stock in AstraZeneca
Marcia Angell, former editor of the New England Journal of Medicine and a leading critic of the Big Pharma, puts it more bluntly: "Psychiatrists are in the pocket of industry." Angell has pointed out that most of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the bible of mental health clinicians, have ties to the drug industry. Likewise, a 2009 study showed that 18 out of 20 of the shrinks who wrote the American Psychiatric Association's most recent clinical guidelines for treating depression, bipolar disorders, and schizophrenia had financial ties to drug companies.

In a recent article in The New York Review of Books, Angell deconstructs what she calls an apparent "raging epidemic of mental illness" among Americans. The use of psychoactive drugs—including both antidepressants and antipsychotics—has exploded, and if the new drugs are so effective, Angell points out, we should "expect the prevalence of mental illness to be declining, not rising." Instead, "the tally of those who are so disabled by mental disorders that they qualify for Supplemental Security Income (SSI) or Social Security Disability Insurance (SSDI) increased nearly two and a half times between 1987 and 2007 - from one in 184 Americans to one in seventy-six. For children, the rise is even more startling - a thirty-five-fold increase in the same two decades. Mental illness is now the leading cause of disability in children." Under the tutelage of Big Pharma, we are "simply expanding the criteria for mental illness so that nearly everyone has one." Fugh-Berman agrees: In the age of aggressive drug marketing, she says, "Psychiatric diagnoses have expanded to include many perfectly normal people."
Cost benefit analysis
What's especially troubling about the over-prescription of the new antipsychotics is its prevalence among the very young and the very old - vulnerable groups who often do not make their own choices when it comes to what medications they take. Investigations into antipsychotic use suggest that their purpose, in these cases, may be to subdue and tranquilize rather than to treat any genuine psychosis.
Carl Elliott reports in Mother Jones magazine: "Once bipolar disorder could be treated with atypicals, rates of diagnoses rose dramatically, especially in children. According to a recent Columbia University study, the number of children and adolescents treated for bipolar disorder rose 40-fold between 1994 and 2003." And according to another study, "one in five children who visited a psychiatrist came away with a prescription for an antipsychotic drug."
A remarkable series published in the Palm Beach Post in May true revealed that the state of Florida's juvenile justice department has literally been pouring these drugs into juvenile facilities, "routinely" doling them out "for reasons that never were approved by federal regulators." The numbers are staggering: "In 2007, for example, the Department of Juvenile Justice bought more than twice as much Seroquel as ibuprofen. Overall, in 24 months, the department bought 326,081 tablets of Seroquel, Abilify, Risperdal and other antipsychotic drugs for use in state-operated jails and homes for children…That's enough to hand out 446 pills a day, seven days a week, for two years in a row, to kids in jails and programs that can hold no more than 2,300 boys and girls on a given day." Further, the paper discovered that "One in three of the psychiatrists who have contracted with the state Department of Juvenile Justice in the past five years has taken speaker fees or gifts from companies that make antipsychotic medications."
In addition to expanding the diagnoses of serious mental illness, drug companies have encouraged doctors to prescribe atypical anti-psychotics for a host of off-label uses. In one particularly notorious episode, the drugmaker Eli Lilly pushed Zyprexa on the caregivers of old people with Alzheimer's and other forms of dementia, as well as agitation, anxiety, and insomnia. In selling to nursing home doctors, sales reps reportedly used the slogan "five at five"meaning that five milligrams of Zyprexa at 5 pm would sedate their more difficult charges. The practice persisted even after FDA had warned Lilly that the drug was not approved for such uses, and that it could lead to obesity and even diabetes in elderly patients.

In a video interview conducted in 2006, Sharham Ahari, who sold Zyprexa for two years at the beginning of the decade, described to me how the sales people would wangle the doctors into prescribing it. At the time, he recalled, his doctor clients were giving him a lot of grief over patients who were "flipping out" over the weight gain associated with the drug, along with the diabetes. "We were instructed to downplay side effects and focus on the efficacy of drug…to recommend the patient drink a glass a water before taking a pill before the meal and then after the meal in hopes the stomach would expand" and provide an easy way out of this obstacle to increased sales. When docs complained, he recalled, "I told them, ‘Our drug is state of the art. What's more important? You want them to get better or do you want them to stay the same--a thin psychotic patient or a fat stable patient.'"
For the drug companies, Shahrman says, the decision to continue pushing the drug despite side effects is matter of cost benefit analysis: Whether you will make more money by continuing to market the drug for off-label use, and perhaps defending against lawsuits, than you would otherwise. In the case of Zyprexa, in January 2009, Lilly settled a lawsuit brought by with the US Justice Department, agreeing to pay $1.4 billion, including "a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind,''the Department of Justice said in announcing the settlement." But Lilly's sale of Zyprexa in that year alone was over $1.8 billion.

Making patients worse

As it turns out, the atypical antipsychotics may not even be the best choice for people with genuine, undisputed psychosis.
A growing number of health professionals have come to think these drugs are not really as effective as older, less expensive medicines which they have replaced, that they themselves produce side effects that cause other sorts of diseases such as diabetes and plunge the patient deeper into the gloomy world of serious mental disorder. Along with stories of success come reports of people turned into virtual zombies.
Elliott reports in Mother Jones: "After another large analysis in The Lancet found that most atypicals actually performed worse than older drugs, two senior British psychiatrists penned a damning editorial that ran in the same issue. Dr. Peter Tyrer, the editor of the British Journal of Psychiatry, and Dr. Tim Kendall of the Royal College of Psychiatrists wrote: "The spurious invention of the atypicals can now be regarded as invention only, cleverly manipulated by the drug industry for marketing purposes and only now being exposed."
Bottom line: Stop Big Pharma and the parasitic shrink community from wantonly pushing these pills across the population.

Who has the Number One U.S. Ranking in Criminal Fraud Cases? BigPharma of Course

This is a portion of the New York Times article Oct. 2nd 2010 by Duff Wilson “Side Effect may include Lawsuits”.

The new generation of antipsychotics has also become the single biggest target of the False Claims Act, a federal law once largely aimed at fraud among military contractors. Every major company selling the drugs Bristol-Myers Squibb, Eli Lilly, Pfizer, AstraZeneca and Johnson & Johnson has either settled recent government cases for hundreds of millions of dollars or is currently under investigation for possible health care fraud.
Two of the settlements, involving charges of illegal marketing, set records last year for the largest criminal fines ever imposed on corporations. One involved Eli Lilly’s antipsychotic, Zyprexa; the other involved a guilty plea for Pfizer’s marketing of a pain pill, Bextra. In the Bextra case, the government also charged Pfizer with illegally marketing another antipsychotic, Geodon; Pfizer settled that part of the claim for $301 million, without admitting any wrongdoing.
The companies all say their antipsychotics are safe and effective in treating the conditions for which the Food and Drug Administration has approved them — mostly, schizophrenia and bipolar mania and say they adhere to tight ethical guidelines in sales practices. The drug makers also say that there is a large population of patients who still haven’t taken the drugs but could benefit from them.
AstraZeneca, which markets Seroquel, the top-selling antipsychotic since 2005, says it developed such drugs because they have fewer side effects than older versions.
“It’s a drug that’s been studied in multiple clinical trials in various indications,” says Dr. Howard Hutchinson, AstraZeneca’s chief medical officer. “Getting these patients to be functioning members of society has a tremendous benefit in terms of their overall well-being and how they look at themselves, and to get that benefit, the patients are willing to accept some level of side effects.”
The industry continues to market antipsychotics aggressively, leading analysts to question how drugs approved by the Food and Drug Administration for about 1 percent of the population have become the pharmaceutical industry’s biggest sellers despite recent crackdowns.

“It’s the money,” says Dr. Jerome L. Avorn, a Harvard medical professor and researcher. “When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.”

Contentions that the new drugs are superior have been “greatly exaggerated,” says Dr. Jeffrey A. Lieberman, chairman of the psychiatry department at Columbia University. Such assertions, he says, “may have been encouraged by an overly expectant community of clinicians and patients eager to believe in the power of new medications.”
“At the same time,” he adds, “the aggressive marketing of these drugs may have contributed to this enhanced perception of their effectiveness in the absence of empirical evidence.”
Others agree. “They sold the story they’re more safe, when they aren’t,” says Robert Whitaker, a journalist who has written two books about psychiatric medicines. “They had to cover up the problems. Right from the start, we got this false story.” End of NYTimes exerpt.

The antidepressant pharmaceutical industry takes in $14.6 Billion in revenue selling these drugs that don’t work. If a firm is taking in this type of money it is easy to settle multi-million dollar fraud lawsuits. The media, government, and medical industry are all working together to cover up the facts that antidepressants don’t work at all so the public is just dumbed down and uninformed on the subject. We commend the NYTimes for doing the research for this article. A truely ethical and independent FDA could stop this madness.

Foster kids, psychotropic prescriptions- finally alarm

Foster Kids have been continually drugged by the social services system in Florida. There have been many articles highlighting this desperate saga where neglected kids get drugged and some have committed suicide while under the guidance of Florida Government Services. The Florida governments only solution is drugs, drugs, drugs…

This is a recent article by Fred Grimm of the MiamiHerald
Foster kids, prescriptions -- finally alarm

Gabriel Myers finally matters.

Too late for him -- the foster kid we addled with anti-depressants and anti-psychotics without quite knowing the effects drug cocktails might have on a 7-year-old.
One potential side effect of feeding Lexapro, Zyprexa and Symbyax to a 67-pound child became grotesquely obvious. Young Gabriel coiled a shower hose around his neck and hanged himself in the bathroom of his Miramar foster home.
Gabriel's death on April 15 roiled child advocates, critics of the pharmaceutical industry, the media. But this week, a child's suicide finally elicited a reaction where it matters.
``I tell you, we're going to do something. We're going to do a full-court press,'' said State Sen. Tony Hill, a Jacksonville Democrat, still shocked after members of the Senate Children, Families and Elder Affairs Committee were briefed Wednesday by the Gabriel Myers Task Force.
UNACCEPTABLE
Committee Chair Rhonda Storms, a Valrico Republican, told reporters, ``I cannot accept or believe that a little child cannot be reached except by drugging him and drugging him and drugging him.''
The task force catalogued drug regimens for foster children that the FDA never approved for children. It described a system blighted by haphazard oversight. No one within the child-care bureaucracy took direct responsibility for the child's complex psychological needs. No one was looking out for a profoundly troubled child's best interest.
Hill railed that Gabriel's foster parents, schools, case workers and doctors hardly spoke to one another as his problems escalated. ``No communication,'' he said, his voice rising in anger.
No one acted as a parent. A vigilant, caring parent would have questioned a pharmaceutical solution to the little boy's behavior. Child advocate Andrea Moore read the task force report and worried that the doctors had responded more to bureaucratic needs of the system than the therapeutic needs of children. About 22 percent of the foster children aged 6 to 12, and a third of foster kids 13 to 17, are on psychiatric drugs. Such numbers, utterly out of whack with the general population, defy any explanation other than foster kids were to be transformed into compliant little zombies.
``We're going to find out,'' Hill promised, describing a bipartisan fury. ``We're going to find out why doctors are writing these prescriptions, and we're going to find out about the relationship between the doctors and drug companies.''
`MAJOR CHANGE'
Advocates like Moore have long complained that state foster care facilities administered psychotropics in lieu of providing real therapy. Five years ago, the Legislature passed supposed safeguards to rein in the pill madness. Obviously, they didn't work.
Meanwhile, pharmaceutical companies have been encouraging doctors to prescribe unapproved, off-label uses for their expensive, profitable drugs.
DCF has promised to revisit psychotropics regulations. Hill promised tough legislation. ``Major, major change is coming. The whole committee is behind this.'' He said drug companies ``can lobby all they want. They can't stop this.''
It took the death of a child to arouse the legislators. ``I admit, I didn't know this was going on before Gabriel,'' Hill said, using the boy's name to describe a tragic event. ``That should never have happened to a child.''
But now, hopefully, it matters.

Legalized Drug Abuse-The Subscription Prescription

If you visit a hospital psychiatrist invariable after a fifteen minute visit and answering a few questions you will be prescribed Zoloft or another brand name antidepressant. You will get a hefty bill for no effort and an ever increasing need for more of Bigpharma’s pills that kill. You will not even get counseling since that takes time and effort. Prescribing a pill is far less labor intensive and a greater bang for a hospitals buck. This is the new mainstream health care system run by pharmaceutical companies as the drug pusher. It's a system that will get you in and out fast and taking an expensive pill, which you will need daily or weekly. It's convenient, and a "subscription prescription" (like phone service or magazines). You will have to resubscribe your prescription. The pharmaceutical drug may not be addictive, but it has side effects, so you will need another drug. The whole drug scheme feeds itself.

There are millions of U.S. seniors taking psychotropic drugs, antidepressants, and Alzheimer's medicines. The number of seniors taking these drugs like Zyprexa has doubled since 1996. There has been an almost 75% increase for seniors and 50% for children during this period. It is more and more because doctors prescribe psychotropic drugs as the first and often only treatment, even when they're not the optimum solution (Read On the Take by Jerome P. Kassirer M.D). Increasingly, when you see your doctor and tell them that you are suffering stress related anxiety they will hand you a prescription of Prozac, Zyprexa, Effexor or whatever the drug the pharmaceutical representative is pushing that month. You would be better off opting instead to exercise and change your diet. Diet and exercise will improve depression naturally. In addition, the side effects of these drugs are appalling.

Typically side effects for the duration of your diagnosis from your fifteen minute visit are suicide, aggressive thoughts, erectile dysfunction, lactating breasts on men, insomnia, anxiety, nightmares, panic attacks, loss of taste and feel, feeling foggy or drugged out, more depressed, bleeding from the nose, nausea, headaches, weight gain just to name a few.

Now would you prefer diet and exercise instead? Stop and think about it. Your great grandparents and grandparents survived both World Wars, and provided a future for you and without taking one pill.